Open original FDA record ↗Recall record
- FDA identifier
- Z-0468-2022
- Company in FDA record
- Getinge Usa Sales Inc
- FDA record creation date
- Jan 10, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
A potential chemical degradation of Sevoflurane by Lewis acids (metal oxides and metal halides) has been discovered that may result in inhalation and/or skin exposure of hydrogen fluoride.
Source facts
- Action
- On December 9, 2021, the firm began distribution of Urgent Medical Device Recall letters to affected customers. Customers were informed of the product issue and potential risks to health, which may include irritation of respiratory tract and in worst case may lead to lung edema and/or severe hypocalcemia which may be delayed for 24-48 hours after exposure. Actions to be taken by the Customer: " Please examine your inventory immediately to determine if you have any of the Vaporizer Sevoflurane, Maquet Filling with the product codes/serial numbers listed in this notice. " Should you have any affected product, please remove from areas of use. " If you have affected product you are entitled to a credit or replacement; however, replacements for use with Sevoflurane from Baxter and Piramal will not be available for some time. " If you use agents from AbbVie ONLY, you can be provided a replacement Vaporizer, Model 6886601, by certifying use of AbbVie agents only on the Medical Device Recall Response Form on page 5. " Please contact Getinge Customer Service at 888-943-8872 (press option 2) to request a return authorization (RMA) and shipping instructions to return any affected product. Pack the product to be returned with the appropriate return documents and, using the shipping instructions provided, arrange for pickup with the designated delivery service provider. " Please enter the serial number and your RMA number provided by Customer Service in the spaces provided on the Medical Device Recall Response Form on Page 5 of this letter. " If at any time, should the user notice that the agent in the vaporizer looks cloudy and yellowish and/or detect a sweet-smelling pungent odor, the user should immediately stop use of the affected vaporizer. " To prevent exposure, the user should be able to successfully perform a System Check-Out (SCO) procedure which may detect the failure prior to usage. If the gas analyzer test fails, a dialog box will appear to promptly inform t
- Initiated
- 2021-12-09
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution - US Nationwide distribution in the states of VA and MO. The countries of Austria, Bahrain, Bolivia, Brazil, Bulgaria, Chile, China, Colombia, Estonia, Iraq, Israel, Italy, Japan, Kenya, Malaysia, Mexico, Morocco, Nicaragua, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Portugal, Saudi Arabia, Singapore, South Africa, Thailand, Trinidad and Tobago, Tunisia, Turkey, United Arab Emirates, United Kingdom, and Vietnam.
- Recall number
- Z-0468-2022
- Recall status
- Open, Classified
- CDRH record ID
- 190581
- FDA record created
- 2022-01-10
- Recall event number
- 89125